ASX - By Stock
|
MSB |
Re:
interleukin-11
|
|
GMFJ
|
7 |
3.4K |
5 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
7
|
3.4K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
GMFJ
|
10K |
3.1M |
0 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
10K
|
3.1M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
GMFJ
|
10K |
3.1M |
1 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
10K
|
3.1M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
GMFJ
|
10K |
3.1M |
8 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
10K
|
3.1M
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
GMFJ
|
25K |
12M |
17 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
25K
|
12M
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
GMFJ
|
549 |
183K |
13 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
549
|
183K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
GMFJ
|
1.0K |
430K |
0 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
1.0K
|
430K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Partnership deals......
|
|
GMFJ
|
102 |
21K |
8 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
102
|
21K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
GMFJ
|
17K |
6.8M |
9 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
17K
|
6.8M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
GMFJ
|
549 |
183K |
40 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
183K
|
40
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
GMFJ
|
943 |
401K |
2 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
943
|
401K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
GMFJ
|
943 |
401K |
0 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
943
|
401K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
GMFJ
|
943 |
401K |
3 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
943
|
401K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
IMU product line - CF33
|
|
GMFJ
|
48 |
24K |
16 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
48
|
24K
|
16
|
|
ASX - By Stock
|
IMU |
Re:
IMU product line - CF33
|
|
GMFJ
|
48 |
24K |
4 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
48
|
24K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
GMFJ
|
25K |
12M |
23 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
25K
|
12M
|
23
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
GMFJ
|
25K |
12M |
15 |
01/01/24 |
01/01/24 |
ASX - By Stock
|
25K
|
12M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
GMFJ
|
17K |
6.8M |
14 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
17K
|
6.8M
|
14
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
GMFJ
|
14K |
7.0M |
2 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
14K
|
7.0M
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene and NeoImmuneTech to Improve Cancer Treatments
|
|
GMFJ
|
96 |
46K |
51 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
96
|
46K
|
51
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
GMFJ
|
716 |
205K |
14 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
716
|
205K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
GMFJ
|
17K |
6.8M |
4 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
17K
|
6.8M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
GMFJ
|
574 |
199K |
7 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
574
|
199K
|
7
|
|
ASX - By Stock
|
MSB |
What are your thoughts on funding?
|
|
GMFJ
|
52 |
15K |
10 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
52
|
15K
|
10
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MESO watch and banter
|
|
GMFJ
|
400 |
153K |
3 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
400
|
153K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Director Appointed to Strategic Advisory Role
|
|
GMFJ
|
106 |
45K |
13 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
106
|
45K
|
13
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MESO watch and banter
|
|
GMFJ
|
400 |
153K |
36 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
400
|
153K
|
36
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
GMFJ
|
10K |
3.1M |
1 |
01/06/23 |
01/06/23 |
ASX - By Stock
|
10K
|
3.1M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Reports Q3 Financial Results and Operational Highlights
|
|
GMFJ
|
362 |
115K |
2 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
362
|
115K
|
2
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Company Presentation
|
|
GMFJ
|
264 |
102K |
7 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
264
|
102K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
GMFJ
|
17K |
6.8M |
16 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
17K
|
6.8M
|
16
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
GMFJ
|
10K |
3.1M |
3 |
10/05/23 |
10/05/23 |
ASX - By Stock
|
10K
|
3.1M
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Capital Raising Presentation
|
|
GMFJ
|
226 |
56K |
2 |
27/04/23 |
27/04/23 |
ASX - By Stock
|
226
|
56K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Bunch of losers?
|
|
GMFJ
|
63 |
17K |
9 |
08/04/23 |
08/04/23 |
ASX - By Stock
|
63
|
17K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
GMFJ
|
10K |
3.1M |
2 |
07/04/23 |
07/04/23 |
ASX - By Stock
|
10K
|
3.1M
|
2
|
|
ASX - By Stock
|
CYP |
Re:
CYP For Sale @ $10 to $20
|
|
GMFJ
|
149 |
49K |
0 |
05/04/23 |
05/04/23 |
ASX - By Stock
|
149
|
49K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
GMFJ
|
17K |
6.8M |
4 |
27/03/23 |
27/03/23 |
ASX - By Stock
|
17K
|
6.8M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
GMFJ
|
1.0K |
395K |
3 |
20/03/23 |
20/03/23 |
ASX - By Stock
|
1.0K
|
395K
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MESOBLAST CURES SR-aGVHD IN CHILDREN
|
|
GMFJ
|
81 |
37K |
34 |
18/02/23 |
18/02/23 |
ASX - By Stock
|
81
|
37K
|
34
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD
|
|
GMFJ
|
914 |
293K |
3 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
914
|
293K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
GMFJ
|
17K |
6.8M |
34 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
17K
|
6.8M
|
34
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
GMFJ
|
17K |
6.8M |
2 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
17K
|
6.8M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
GMFJ
|
17K |
6.8M |
25 |
07/11/22 |
07/11/22 |
ASX - By Stock
|
17K
|
6.8M
|
25
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
GMFJ
|
17K |
6.8M |
24 |
05/11/22 |
05/11/22 |
ASX - By Stock
|
17K
|
6.8M
|
24
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
GMFJ
|
17K |
6.8M |
26 |
03/11/22 |
03/11/22 |
ASX - By Stock
|
17K
|
6.8M
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Submits New Information to FDA IND File for SR-aGVHD
|
|
GMFJ
|
576 |
206K |
7 |
02/11/22 |
02/11/22 |
ASX - By Stock
|
576
|
206K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
GMFJ
|
17K |
6.8M |
11 |
17/10/22 |
17/10/22 |
ASX - By Stock
|
17K
|
6.8M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
GMFJ
|
4.7K |
1.1M |
7 |
12/10/22 |
12/10/22 |
ASX - By Stock
|
4.7K
|
1.1M
|
7
|
|
ASX - By Stock
|
MSB |
Ah, what the hell.
|
|
GMFJ
|
2 |
1.2K |
25 |
30/09/22 |
30/09/22 |
ASX - By Stock
|
2
|
1.2K
|
25
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
GMFJ
|
10K |
3.1M |
4 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
10K
|
3.1M
|
4
|
|